Healthcare


 3 FTSE AIM Pharma Stocks That Have Given Returns of Over 100% In a Year

3 FTSE AIM Pharma Stocks That Have Given Returns of Over 100% In a Year

May 13, 2021 02:01 PM BST| By Suhita Poddar

Pharmaceuticals and biotechnology stocks have gained attention in recent times, especially vaccine related stocks, due to their contribution in the fight against the pandemic. But, aside from pharma giants, the rest of the pharmaceutical and biotec.....

 Four Small-Cap Healthcare Stocks That Have Given Over 50 Per Cent Return in A Year

Four Small-Cap Healthcare Stocks That Have Given Over 50 Per Cent Return in A Year

May 12, 2021 12:52 PM BST| By Abhijeet

Summary Over the last year, the biotechnology and pharmaceuticals index has been the second-worst performer in the FTSE350 Index. Healthcare stocks are a risky investment as these biotechnology firms work on breakthrough scientific research, wh.....

 A Glance at 5 Healthcare Penny Stocks

A Glance at 5 Healthcare Penny Stocks

May 08, 2021 12:30 AM BST| By Suhita Poddar

Summary Second phase of coronavirus and new mutations seek advanced healthcare supplies. Vaccine rollout has not affected the demand for test kits and scanning machines. Manufacturers and distributors of diagnostic solutions are gaining invest.....

 Vaccine Stocks in News: Pfizer’s Profits Rise, AstraZeneca Faces Opposition to CEO’s Bonus Hike

Vaccine Stocks in News: Pfizer’s Profits Rise, AstraZeneca Faces Opposition to CEO’s Bonus Hike

May 05, 2021 12:42 PM BST| By Suhita Poddar

Summary Pfizer predicts US$ 26 billion from sales of Covid-19 vaccine in 2021 Proposed bonus hike for AstraZeneca’s CEO to be opposed by investors Over 1.18 billion Covid-19 vaccine doses have been administered across the globe as of.....

 What are the foundation stones laid by Tristel to resume revenue and profit growth from FY22?

What are the foundation stones laid by Tristel to resume revenue and profit growth from FY22?

April 26, 2021 04:08 PM BST| By Team Kalkine Media

Summary TSTL expects FY21 global sales to remain around £31 million for the year ending on 30 June 2021. The surface disinfectant product sales in the UK had witnessed a 47% growth to £2.3 million during Q3 FY21. TSTL had anticipat.....

 How These 2 Healthcare Stocks Performed Amid Pandemic Challenge

How These 2 Healthcare Stocks Performed Amid Pandemic Challenge

April 16, 2021 01:13 PM BST| By Suhita Poddar

Source: BlurryMe, Shutterstock Summary: UK's leading cell and gene therapy firm Oxford Biomedica reported a 37 per cent increase in its revenue to £87.7 million for FY20. PureTech’s operating losses shrunk from $135.39 million in 201...

 Crypto Kings: Extraordinary Tale of Coinbase Founders Brian Armstrong, Fred Ehrsam

Crypto Kings: Extraordinary Tale of Coinbase Founders Brian Armstrong, Fred Ehrsam

April 15, 2021 10:18 AM BST| By Team Kalkine Media

Source: DSkorynko, Shutterstock Summary Although Coinbase made a smashing debuted on NASDAQ, opening 4% higher than the reference price, the Company had humble beginnings. Co-founders Fred Ehrsam and Brian Armstrong met on Reddit and built the...

 Covid-19 Vaccine Makers in News: J&J, AstraZeneca and Pfizer

Covid-19 Vaccine Makers in News: J&J, AstraZeneca and Pfizer

April 14, 2021 10:45 AM BST| By Suhita Poddar

Source: insta_photos, Shutterstock Summary J&J delays the distribution of its Covid-19 vaccine to Europe. US may not use the AstraZeneca vaccine, says the chief pandemic adviser to the White House. Pfizer is likely to meet its US supply t...

 AstraZeneca’s Farxiga Fails to Yield Statistical Significance for Covid-19 Treatment

AstraZeneca’s Farxiga Fails to Yield Statistical Significance for Covid-19 Treatment

April 12, 2021 11:27 AM BST| By Suhita Poddar

and concerns of using SGLT2 inhibitors to treat Covid-19 patients admitted to hospital. Things are not at all smooth for the pharma major AstraZeneca Plc (LON: AZN). After getting mired in various controversies related to its Covid-19 vaccine (....

 EMA Supports Astrazeneca Jabs Despite Links with Rare Blood Clots

EMA Supports Astrazeneca Jabs Despite Links with Rare Blood Clots

April 07, 2021 04:55 PM BST| By Abhijeet

Source: LookerStudio, Shutterstock Summary The European Medicines Agency has said that the benefits of using AstraZeneca vaccine outweigh the potential risks it had highlighted before.  The MHRA is also scheduled to come up with an up...

 10 Cheap Healthcare Stocks to Ponder Over This Easter

10 Cheap Healthcare Stocks to Ponder Over This Easter

April 05, 2021 12:37 AM BST| By Abhijeet

Source: Guschenkova, Shutterstock Summary On a YTD scale, healthcare stocks have multiplied the investors’ wealth by almost 2.5 times. Healthcare sector has a lot of ground to cover, and businesses can access a huge door of growth opport...

 Moderna vaccine to be rolled out in April as UK aims to vaccinate all adults by July

Moderna vaccine to be rolled out in April as UK aims to vaccinate all adults by July

March 29, 2021 06:37 PM BST| By Abhijeet

Source: insta_photos, Shutterstock Summary The UK authorities said that first jabs of Moderna vaccine would be rolled out in April. The Boris Johnson government had said that it was committed to its plans to vaccinate the entire adult populati...

 Astrazeneca Vaccine Less Effective Than Earlier Touted, Claims Latest Trial Results

Astrazeneca Vaccine Less Effective Than Earlier Touted, Claims Latest Trial Results

March 25, 2021 10:47 AM GMT| By Abhijeet

Source: PhotobyTawat, Shutterstock Summary The Oxford-AstraZeneca vaccine is 76 per cent effective against the coronavirus infection. The earlier US clinical trial results had put the value a tad higher at 79 per cent. Despite the lower rate,...

 AstraZeneca Shares Making ‘Inverse Head And Shoulders’ Pattern Amid Vaccine Chaos

AstraZeneca Shares Making ‘Inverse Head And Shoulders’ Pattern Amid Vaccine Chaos

March 19, 2021 02:50 PM GMT| By Abhijeet

Source: PhotobyTawat, Shutterstock Summary Shares of AstraZeneca have experienced a turbulent trading session of late. The stock was trading at GBX 7,133, up 0.07 per cent on 19 March. This year so far, the stock has largely fallen extending...

 Vaccine Stocks in Focus as AstraZeneca Awaits EU Verdict on Its Jabs

Vaccine Stocks in Focus as AstraZeneca Awaits EU Verdict on Its Jabs

March 16, 2021 04:00 PM GMT| By Suhita Poddar

Source: Aedka Studio, Shutterstock Summary AstraZeneca has recently faced suspensions from several countries and now is awaiting the EU medical watchdog’s official verdict. The company’s shares are still in the green as the World H...

 4 Aspects That Can Decide The Future Of Vaccines

4 Aspects That Can Decide The Future Of Vaccines

March 15, 2021 03:20 PM GMT| By Abhijeet

Source: insta_photosy, Shutterstock Summary The future of vaccines will depend on several factors such as efficacy of next-generation vaccines, logistical, and distribution issues, fast-tracking approvals and latest innovations and technology....

 Vaccine stocks in focus as UK rejects EU’s vaccine export ban claims

Vaccine stocks in focus as UK rejects EU’s vaccine export ban claims

March 10, 2021 04:14 PM GMT| By Team Kalkine Media

Source: PalSand, Shutterstock  Summary The British government denied false EU claims over vaccine nationalism concerns. Pandemic seems to have proved the worth of prominent vaccine stocks – AZN, MRNA, PFE and BNTX.   A di...

 Why Moderna, Pfizer Et Al Are Poised for Strong Gains in FY 2021

Why Moderna, Pfizer Et Al Are Poised for Strong Gains in FY 2021

March 08, 2021 02:03 PM GMT| By Suhita Poddar

Source: LookerStudio, Shutterstock Summary Several pharmaceutical companies, such as Moderna, Pfizer-BioNTech, Astrazeneca, and others are expected to report huge revenues in FY 2021 as vaccination rollouts gain momentum across the world. Tota...

 3 FTSE 250 healthcare stocks with over 25% return in last one year 

3 FTSE 250 healthcare stocks with over 25% return in last one year 

February 28, 2021 12:58 AM GMT| By Team Kalkine Media

Source: janews, Shutterstock  Summary Three FTSE 250 index stocks have given over 25 per cent return on investment in the last one year. Dechra Pharmaceuticals gave 25.16 per cent, Genus Plc 54.21 per cent, and PureTech Hea...

 Will Moderna’s booster shots be effective on South African variant? 

Will Moderna’s booster shots be effective on South African variant? 

February 25, 2021 04:01 PM GMT| By Team Kalkine Media

Source: joel bubble ben, Shutterstock Summary Moderna said that it has been able to produce booster shots particularly for the South African variant. The shots have been shipped to the National Institutes of Health in...

Recent Articles






Investing Tips

Previous Next